APLS - Apellis Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

APLS is currently covered by 15 analysts with an average price target of $36.07. This is a potential upside of $9.6 (986.45%) from yesterday's end of day stock price of $3.32.

Apellis Pharmaceuticals's activity chart (see below) currently has 380 price targets and 311 ratings on display. The stock rating distribution of APLS is 38.89% HOLD and 61.11% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 67.65% with an average time for these price targets to be met of 205.92 days.

Highest price target for APLS is $52, Lowest price target is $18, average price target is $36.07.

Most recent stock forecast was given by from CANTOR FITZGERALD on 15-May-2026. First documented stock forecast 04-Dec-2017.

Currently out of the existing stock ratings of APLS, 14 are a HOLD (38.89%), 22 are a BUY (61.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 15-May-2026

$31

1 months 23 days ago
(15-May-2026)

4/22 (18.18%)

$13.11 (73.28%)

308

Buy Since 20-Jan-2026

$41

$37.23 (987.53%)

$26

2 months 21 days ago
(17-Apr-2026)

15/18 (83.33%)

$0.1 (0.24%)

100

Hold Since 02-Nov-2023

$41

$37.23 (987.53%)

$20

3 months 6 days ago
(02-Apr-2026)

14/19 (73.68%)

$0.59 (1.46%)

147

Buy Since 19-Jul-2022

$41

$37.23 (987.53%)

$48

3 months 7 days ago
(01-Apr-2026)

4/29 (13.79%)

$0.61 (1.51%)

90

Buy Since 19-Jan-2024

$41

$37.23 (987.53%)

$45

3 months 7 days ago
(01-Apr-2026)

16/28 (57.14%)

$0.61 (1.51%)

368

Show more analysts

Please expand the browser size to see the chart

What is APLS (Apellis Pharmaceuticals) average time for price targets to be met?

On average it took 205.92 days on average for the stock forecasts to be realized with a an average price target met ratio 67.65

Which analyst has the current highest performing score on APLS (Apellis Pharmaceuticals) with a proven track record?

COLLEEN KUSY

Which analyst has the most public recommendations on APLS (Apellis Pharmaceuticals)?

Colleen Kusy works at BAIRD and has 5 price targets and 5 ratings on APLS

Which analyst is the currently most bullish on APLS (Apellis Pharmaceuticals)?

Madhu Kumar with highest potential upside - $100.21

Which analyst is the currently most reserved on APLS (Apellis Pharmaceuticals)?

Steven Seedhouse with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?